MENU
MAY 30, 2017 9:00 AM PDT

Protein and Cell Analysis Education Series featuring the Antibody Validation Forum

Speakers
  • CEO, Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada; International Working Group for Antibody Validation (IWGAV) member
    BIOGRAPHY
  • Director of Strategy and Partnering for Antibodies and Immunoassay, Biosciences Division, Thermo Fisher Scientific
    BIOGRAPHY
  • Scientific Lead, Neuroscience Information Framework, Center for Research in Biological Systems, University of California at San Diego, San Diego, California, USA; Founder and CEO of SciCrunc
    BIOGRAPHY
  • Professor of Oncology, and Director, Flow and Image Cytometry Facility, Roswell Park Cancer Institute, Buffalo, NY, USA; Associate Professor of Pathology, State University of New York at Buff
    BIOGRAPHY
  • Senior R&D Manager, Mass Spectrometry Reagents, Protein and Cell Analysis, Biosciences Division, Thermo Scientific
    BIOGRAPHY
  • Vice President of R&D for Protein and Cell Analysis, and Antibodies and Immunoassays, Biosciences Division, Thermo Fisher Scientific
    BIOGRAPHY

Abstract

Addressing the antibody reproducibility crisis: A panel discussion with key scientific leaders

 

Reproducibility and antibody validation standards are two significant challenges facing scientific researchers today.  To address these issues, Thermo Fisher Scientific—a leading producer of antibodies— organized and supported a group of leading researchers from several global institutions. This International Working Group for Antibody Validation (IWGAV) brainstormed and developed a set of proposed standards to optimize antibody validation methods with a specific emphasis on antibody specificity verification.  As a follow up, in fall 2016, the Global Biological Standards Institute (GBSI) hosted a meeting attended by several IWGAV members and representatives from antibody producers, pharmaceutical companies and leading academic research labs. Attendees reviewed and validated the IWGAV proposed standards and discussed strategies designed to implement these standards across the industry.  

 

In this event, Thermo Fisher Scientific will host a live, virtual round table discussion in which representative IWGAV members and others from the research community will participate in a dialogue about antibody validation standards and practices, with the goal of finding consensus for how to further methods for verifying antibodies used for common laboratory techniques—such as western blotting, ELISA, immunohistochemistry, immunofluorescence. The panel will also discuss how these new standards may be adapted to validate antibodies intended for flow cytometry.

 

ADDITIONAL PRESENTATIONS

SESSION 2-WEBINAR

Time: 10:00 AM PDT

Antibody validation with immunoprecipitation/mass spectrometry and orthogonal methods (Login here)

Speaker: John Rogers, PhD, Thermo Fisher Scientific

 

SESSION 3-WEBINAR

Time: 11:00 AM PDT

Super Bright antibody conjugates for flow cytometry—Bright polymer dyes for the violet laser (Login here)

Speaker: Castle Funatake, PhD, Thermo Fisher Scientific

 

SESSION 4-WEBINAR

Time: 12:00 PM PDT

Chemiluminescent western blot detection: Bright and bold detection no matter how scarce your target (Login here)

Speaker: Emily Halbrader, Thermo Fisher Scientific

 

SESSION 5-WEBINAR

Time: 1:00 PM PDT

The new generation in immunoassays (Login here)

Speaker: David Bourdon, PhD, Thermo Fisher Scientific

 


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
MAR 25, 2021 8:00 AM PDT
C.E. CREDITS
MAR 25, 2021 8:00 AM PDT
Date: March 25, 2021 Time: 8:00am (PST), 11:00am (EST) Flow cytometry has expanded to have more users, more data, and multiple instrument types. While this has lead to more quantitative data...
MAY 30, 2017 9:00 AM PDT

Protein and Cell Analysis Education Series featuring the Antibody Validation Forum


Specialty

Biotechnology

Molecular Biology

Cell Biology

Immunology

Cancer Research

Biomarkers

Cell Culture

Antibodies

Biochemistry

Molecular Diagnostics

Laboratory Testing

Clinical Research

Clinical Diagnostics

Assay Development

Cancer Therapeutics

Geography

North America53%

Europe24%

Asia10%

South America4%

Africa2%

Oceania1%

Registration Source

Website Visitors100%

Job Title

Scientist17%

Student15%

Facility/Department Manager14%

Research Scientist13%

Executive13%

Educator/Faculty8%

Post Doc5%

Medical Doctor/Specialist4%

Lab Management4%

Medical Laboratory Technician3%

Clinical Laboratory Scientist2%

Marketing/Sales2%

Biologist1%

Organization

Academic Institution12%

Biotech Company9%

Research Institute5%

Life Science Company4%

Hospital2%

Clinical Laboratory2%

Government2%

Pharmaceutical Company2%

Ambulatory Care2%

Contract Research Organization (Cro)1%

Industrial Company1%

Medical Center1%

Medical School1%

Non-Profit Organization1%

Other4%


Show Resources
Loading Comments...
Show Resources
Attendees
  • See more